Ranked in 1 Practice Areas
4

Band 4

Life Sciences

Japan

3 Years Ranked

About

Provided by Takamasa Horio

Asia-Pacific

Practice Areas

Life Sciences / Healthcare; Crisis Management / Compliance (Internal Investigations, Global Compliance, Whistleblowing); M&A (M&A / Reorganizations / Capital and Business Alliances, Cross-Border M&A, Private Equity, Start-Ups); Intellectual Property (Intellectual Property Transactions, Intellectual Property Disputes); Corporate Law (Corporate Governance)

Career

Background

Doshisha University (LL.B., 2006); Kyoto University Law School (J.D., 2008); Northwestern University School of Law (LL.M. with honors, 2016); Northwestern University School of Law, Kellogg School of Management (Certificate in Business Administration, 2016); Jenner & Block LLP, Chicago (2016-2017); assigned to the Pharmaceutical Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare as a fixed-term government employee (as Legal Adviser) (2017-2020)

Major Activities

Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology⁠, Japan Agency for Medical Research and Development(⁠2020-2022⁠); Member of Study Group on Countermeasures against Cannabis and Other Drugs⁠, Ministry of Health⁠, Labour and Welfare(⁠2020-2021⁠); Member of the Advisory Committee (⁠Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products⁠) for Toyama Pharmaceutical Affairs Council (⁠2021⁠); Adviser for The Japan Federation of Medical Devices Associations (⁠2021-⁠); Member of the Toyama Prefecture GMP Inspection Investigative Committee (⁠2021⁠); Member of Legislation Committee⁠, Japan Pharmaceutical Association (⁠2022-⁠); Member of the Board of Experts for the “⁠Consultation Desk for Clinical Research of Medical Equipment⁠,⁠” Japan Association for the Advancement of Medical Equipment (⁠2024-⁠); Member of the Clinical Trial Ethics Review Board⁠, Cancer Institute Hospital Of JFCR (⁠2025-⁠)

Professional Memberships

admitted in Japan, 2009; Illinois, 2016

Chambers Review

Provided by Chambers

Chambers Asia & Pacific

Life Sciences - Japan

4
Band 4
Individual Editorial

Takamasa Horio is a notable practitioner assisting pharmaceutical and medical device companies with regulatory matters. Clients benefit from his experience working as part of government bodies in the life sciences space.

Strengths

Provided by Chambers

Discover other Lawyers at
Mori Hamada

Provided by Chambers
Filter by
Band

Japan

Banking & Finance: Domestic

1
Hiroki Aoyama
1
Band 1
1
Masanori Sato
1
Band 1
3
Takahiro Kobayashi
3
Band 3
4
Kei Shirakawa
4
Band 4
4
Yusuke Suehiro
4
Band 4
U
Yuki Matsuda
U
Up and Coming
Capital Markets: Domestic

1
Katsumasa Suzuki
1
Band 1
1
Toshimitsu Nemoto
1
Band 1
3
Katsuyuki Tainaka
3
Band 3
3
Taro Omoto
3
Band 3
Capital Markets: Domestic: J-REITs

2
Taro Omoto
2
Band 2
2
Yasuhiko Fujitsu
2
Band 2
Capital Markets: Domestic: Securitisation & Derivatives

1
Akira Ehira
1
Band 1
1
Masanori Sato
1
Band 1
Competition/Antitrust

1
Kenji Ito
1
Band 1
2
Hideki Utsunomiya
2
Band 2
3
Yusuke Takamiya
3
Band 3
Corporate/M&A: Domestic

1
Gaku Ishiwata
1
Band 1
1
Hajime Tanahashi
1
Band 1
4
Atsushi Oishi
4
Band 4
20 of 69 results